Core Points - The company announced the passing of its founder and chairman, Mr. Yin Zhenglong, on August 26, 2025, at the age of 60 [1][2] - Mr. Yin was instrumental in the development of the Chinese pharmaceutical industry, focusing on domestic pharmaceutical excipients and achieving a transition from following to competing internationally [2] - The company will ensure that the board of directors remains functional and will not be affected by Mr. Yin's passing, with interim leadership provided by Mr. Song Daocai [3] Company Overview - Mr. Yin Zhenglong held 63,057,454 shares in the company, representing a significant portion of the total shares [2] - The company has a structured plan to elect a new chairman in accordance with legal regulations and its articles of association [3] - Mr. Song Daocai, currently the general manager, will temporarily assume the role of chairman until a new chairman is elected [3][5] Leadership Background - Mr. Song Daocai, aged 56, has extensive experience within the company, having held various positions since 2008, including production director and general manager [5] - He has a background in economic management and is a licensed pharmacist and engineer [5]
山河药辅: 关于公司控股股东、实际控制人、董事长逝世的公告